Cargando…

Advances with microRNAs in Parkinson’s disease research

Parkinson’s disease (PD) is the second-most common age-dependent neurodegenerative disorder and is caused by severe degeneration of dopaminergic neurons in the substantia nigra pars compacta. Unfortunately, current treatment only targets symptoms and involves dopamine replacement therapy, which does...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Liuqing, Wei, Liangming, Wu, Fei, Hu, Zhenhua, Liu, Zhenguo, Yuan, Weien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792848/ https://www.ncbi.nlm.nih.gov/pubmed/24109179 http://dx.doi.org/10.2147/DDDT.S48500

Ejemplares similares

Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion
por: Hong, Xiaoyun, et al.
Publicado: (2013)

Long-acting preparations of exenatide
por: Cai, Yunpeng, et al.
Publicado: (2013)

Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine
por: Hong, Xiaoyun, et al.
Publicado: (2013)

Role of MicroRNAs in Parkinson’s Disease
por: Goh, Suh Yee, et al.
Publicado: (2019)

Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson’s Disease
por: Chen, Wei, et al.
Publicado: (2016)

Advances with RNA interference in Alzheimer’s disease research
por: Chen, Shun, et al.
Publicado: (2013)

MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
por: Wang, Hsiuying
Publicado: (2021)

Research advances in roles of microRNAs in nasal polyp
por: Zhipu, Niu, et al.
Publicado: (2022)

Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients
por: Jiang, Yanyan, et al.
Publicado: (2021)

MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)

Recent advances in the functional explorations of nuclear microRNAs
por: Hu, Xiaozhu, et al.
Publicado: (2023)

MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease
por: Selvakumar, Sushmaa Chandralekha, et al.
Publicado: (2022)

Computational Prediction of Alzheimer’s and Parkinson’s Disease MicroRNAs in Domestic Animals
por: Wang, Hai Yang, et al.
Publicado: (2016)

pH-sensitive degradable nanoparticles for highly efficient intracellular delivery of exogenous protein
por: Xu, Dan, et al.
Publicado: (2013)

Studying the System-Level Involvement of MicroRNAs in Parkinson's Disease
por: Chatterjee, Paulami, et al.
Publicado: (2014)

Recent advances microRNAs and metabolic reprogramming in colorectal cancer research
por: Xiong, Bin, et al.
Publicado: (2023)

MicroRNAs in autoimmune disease
por: Rauniyar, Vivek K., et al.
Publicado: (2011)

MicroRNAs and Presbycusis
por: Hu, Weiming, et al.
Publicado: (2018)

MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson's Disease
por: Zhao, Liang, et al.
Publicado: (2019)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

MicroRNAs from extracellular vesicles as a signature for Parkinson's disease
por: Caldi Gomes, Lucas, et al.
Publicado: (2021)

CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease
por: Fowler, Alan J., et al.
Publicado: (2021)

MicroRNAs in Sudden Death in Parkinson's Disease: Could the News be Packaged?
por: Guimarães-Marques, Marcia, et al.
Publicado: (2021)

The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease
por: Guedes, Beatriz F. S., et al.
Publicado: (2023)

MicroRNAs in nasopharyngeal carcinoma
por: Bruce, Jeff P., et al.
Publicado: (2014)

Advances in microRNAs: implications for immunity and inflammatory diseases
por: Sonkoly, E, et al.
Publicado: (2009)

Development of dextran nanoparticles for stabilizing delicate proteins
por: Wu, Fei, et al.
Publicado: (2013)

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
por: Yang, Yimin, et al.
Publicado: (2021)

RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis
por: Heman-Ackah, Sabrina M., et al.
Publicado: (2013)

microRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's Disease
por: Xie, Yangmei, et al.
Publicado: (2016)

microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches
por: Leggio, Loredana, et al.
Publicado: (2017)

MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
por: Arshad, Ahmad R., et al.
Publicado: (2017)

Can Circulating microRNAs Identify Sudden Unexpected Death in Parkinson's Disease ?
por: Ramaswamy, Palaniswamy, et al.
Publicado: (2021)

A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease
por: Szelągowski, Adam, et al.
Publicado: (2023)

Research progress on exosomes/microRNAs in the treatment of diabetic retinopathy
por: Niu, Si-ru, et al.
Publicado: (2022)

MicroRNAs and Autoimmune-Mediated Eye Diseases
por: Wei, Yankai, et al.
Publicado: (2020)

Advances in the Application and Impact of MicroRNAs as Therapies for Skin Disease
por: Lawrence, Paul, et al.
Publicado: (2017)

Research Progress on MicroRNAs Involved in the Regulation of Chicken Diseases
por: Wang, Yang
Publicado: (2020)

MicroRNAs and Cardiovascular Disease in Diabetes Mellitus
por: Ding, Yue, et al.
Publicado: (2017)

Recent Advance in Biosensors for microRNAs Detection in Cancer
por: Catuogno, Silvia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jprb55hmtl694co4bb1mrfiehp